retatrutide phase 2 trial obesity nejm 2023 Another Promising Medication (Retatrutide) for Retatrutide Dosage: Titration Schedule |

Pendulum GLP-1 Probiotic Pro is manufactured in GMP-certified facilities and is third-party tested, but it does not carry FDA approval as a treatment for any condition

FDA-approved injectable GLP-1 medications include: Semaglutide (Ozempic 0.5-2 mg weekly for diabetes

Final Thoughts Weight loss scams continue to spread across social media, online ads, and influencer marketing

Patients with diabetic retinopathy must be vigilant of the condition when taking compounded semaglutide to avoid complications

In the Phase 2 trial published in the New England Journal of Medicine (2023), retatrutide was administered as a once-weekly subcutaneous injection using a structured dose-escalation schedule

These can be serious stomach pain, an enlarged pancreas, hypoglycemia in diabetics, and allergic reactions